Liver Neoplasms: all 1,406 studies
Page 8 of 15. Open to participants first (347), then studies with results posted, then the rest; newest registration first within each.
- Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerCompletedNCT04670445Not applicable
- Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)Active, not recruitingNCT04658147Phase 1
- Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCCStatus unknownNCT04653701
- HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular CarcinamaStatus unknownNCT04627363Phase 2
- Volatile Organic Compounds for the Assessment of Liver DiseaseCompletedNCT04620538
- Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver TransplantationCompletedNCT04618692Not applicable
- HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTTCompletedNCT04618367Not applicable
- Bleeding in Laparoscopic Liver SurgeryTerminatedNCT04609410Not applicable
- Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome SequencingCompletedNCT04597710
- Comparison of Criteria for Liver Transplantation in Hepatocellular CarcinomaCompletedNCT04576572
- Prospective Multicenter Study on Clinical Application of Sonazoid in Liver TumorStatus unknownNCT04563897
- Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRIStatus unknownNCT04559451
- Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER CancerCompletedNCT04540081Not applicable
- Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver MetastasesStatus unknownNCT04525326Phase 3
- Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver CancerStatus unknownNCT04523662Phase 2
- TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCCCompletedNCT04518852Phase 2
- Quality of Life of Patients Over 75 Yars Undergoing Palliative ChemotherapyTerminatedNCT04517448
- Effects of Anesthetic Methods on Hepatic Cancer Cell Function in VitroCompletedNCT04510935Not applicable
- Cetuximab Re-challenge for Colorectal Cancer Liver MetastasisStatus unknownNCT04509635Phase 3
- Role of EUS in Detection of Liver MetastasisCompletedNCT04509492
- Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)TerminatedNCT04502082Phase 1
- Camrelizumab Utilization on Patients With Advanced Liver CancerStatus unknownNCT04487704Not applicable
- PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)CompletedNCT04484636Not applicable
- A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesCompletedNCT04440943Phase 1
- A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）WithdrawnNCT04420130Not applicable
- Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic TumorsCompletedNCT04420026Not applicable
- To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency AblationStatus unknownNCT04417010
- Radiofrequency-assisted Liver Resection in Intractable Liver CancerCompletedNCT04413526
- Optimizing Y90 Therapy for Radiation LobectomyActive, not recruitingNCT04390724
- Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsCompletedNCT04374877Phase 1
- Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsTerminatedNCT04348916Phase 1
- Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerWithdrawnNCT04348643Phase 1/2
- Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing SBRT Using Audiovisual BiofeedbackCompletedNCT04323618Not applicable
- Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver TumorsTerminatedNCT04315883
- A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver CancerStatus unknownNCT04309747Not applicable
- Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With CirrhosisCompletedNCT04288323Phase 4
- Colorectal Liver Metastases: Novel Assessment Tools for Technical ResectabilityStatus unknownNCT04270851
- Real-time Imaging of Holmium Radioembolization: a Feasibility StudyCompletedNCT04269499Not applicable
- Characterization of Methylation Patterns in Hepatocellular CarcinomaTerminatedNCT04264754
- Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative TreatmentCompletedNCT04264260Phase 2
- Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
- Patient Skin Dose in Interventional RadiologyCompletedNCT04246125
- Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver TumorsActive, not recruitingNCT04242342Not applicable
- Is Thoracic Paravertebral Block a Better Option Than Conscious Sedation for PRFA of Liver TumorsCompletedNCT04241887Not applicable
- Clinical Application of Nutrition Support Package Before HepatectomyStatus unknownNCT04218253Not applicable
- Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver MetastasesStatus unknownNCT04213222
- Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCCCompletedNCT04212286Not applicable
- Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCCStatus unknownNCT04212273Not applicable
- GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver CancerStatus unknownNCT04206254Phase 2/3
- Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal CancersActive, not recruitingNCT04196465Phase 2
- Feasibility of Ultrasound-based Navigation for Non-anatomical Liver ResectionsTerminatedNCT04187937Not applicable
- SBRT for Liver Cancer Before Liver TransplantationActive, not recruitingNCT04186234Not applicable
- Scandinavian Cohort Study for Optimal Use of Portal Vein EmbolizationStatus unknownNCT04182386
- Impact of Chemotherapy and Regenerative Markers of Liver Regeneration After Liver Resection for Liver MetastasesStatus unknownNCT04178759Not applicable
- Combined Immunotherapy and Targeted Therapy for Advanced Liver CancerStatus unknownNCT04163237Phase 3
- The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer MetastasesActive, not recruitingNCT04161092Not applicable
- Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAETerminatedNCT04150874Early Phase 1
- National Translational Science Network of Precision-based Immunotherapy for Primary Liver CancerCompletedNCT04145141
- Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous AblationCompletedNCT04123340Phase 2
- Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal CancerTerminatedNCT04108481Phase 1
- Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo TrialCompletedNCT04106453Not applicable
- T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)WithdrawnNCT04093648Phase 1
- TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver CancerCompletedNCT04090645Not applicable
- COLLISION XL: Unresectable Colorectal Liver Metastases (3-5cm): Stereotactic Body Radiotherapy vs. Microwave AblationStatus unknownNCT04081168Not applicable
- Evaluation of the Reproducibility of Ablation Volumes at One Month After Microwave Treatment Compared to the Manufacturer's Abacus: on the Kidney, Liver and LungCompletedNCT04072224
- Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor ThrombusStatus unknownNCT04069949Phase 1/2
- The Safety and Efficacy of Spherical Microwave Ablation for the Treatment of Malignant Liver TumorsWithdrawnNCT04044326Not applicable
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Liver Resection ModelingStatus unknownNCT04023136Not applicable
- Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant TumorsStatus unknownNCT04010071Phase 2
- A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorActive, not recruitingNCT04008797Phase 1/2
- Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.Status unknownNCT04003792Phase 2
- Study of ET140202 T Cells in Adults With Advanced Hepatocellular CarcinomaTerminatedNCT03998033Phase 1
- Deportalization, Venous Deprivation, Venous CongestionCompletedNCT03995459
- Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in METActive, not recruitingNCT03993873Phase 1
- EXALT: EXercise Attenuates Liver Tumors TrialTerminatedNCT03979547Not applicable
- A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein InvasionStatus unknownNCT03971201Phase 2
- ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver CancerStatus unknownNCT03965546Early Phase 1
- Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer.Status unknownNCT03963726Not applicable
- Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract CarcinomaActive, not recruitingNCT03937830Phase 2
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary TumorsCompletedNCT03895970Phase 2
- Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver MetastasesStatus unknownNCT03895723Not applicable
- Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer PatientsCompletedNCT03891654Early Phase 1
- Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune SystemTerminatedNCT03889093Not applicable
- ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular CarcinomaCompletedNCT03888859Early Phase 1
- The Role of Tumor-associated Macrophages in Colorectal Liver MetastasesCompletedNCT03888638
- A Percutaneous Ultrasound Device With Needle Guide for Vascular AccessWithdrawnNCT03879161Not applicable
- Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsCompletedNCT03867916Not applicable
- Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentCompletedNCT03847428Phase 3
- Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver CancerStatus unknownNCT03843229Phase 4
- The Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver ResectionCompletedNCT03813953Not applicable
- Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver TransplantationCompletedNCT03803436Phase 2
- A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular CarcinomaActive, not recruitingNCT03778957Phase 3
- Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT03766776Not applicable
- Natural History Study of Children and Adults With Fibrolamellar Hepatocellular CarcinomaWithdrawnNCT03748927
- Application of 3D Printing in Laparoscopic Surgery of Liver TumorsStatus unknownNCT03744624Not applicable
- TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal CancerStatus unknownNCT03732235
- The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in PatientsCompletedNCT03723304
- Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic SurgeryStatus unknownNCT03718078Not applicable